Advertisement
Advertisement
Pfizer signs strategic cooperation pact with China’s Sinopharm
By:
(Reuters) - Pfizer said on Thursday it has signed a strategic cooperation agreement with China's Sinopharm Group, and plans to seek approval to market 12 innovative drugs in China through 2025.
(Reuters) – Pfizer said on Thursday it has signed a strategic cooperation agreement with China’s Sinopharm Group, and plans to seek approval to market 12 innovative drugs in China through 2025.
Sinopharm’s president Liu Yong said during the signing event in Shanghai on Wednesday that the cooperation will involve accelerating the delivery of Pfizer’s new drugs to patients, according to a statement from Pfizer.
(Reporting by Brenda Goh, Meg Shen and Ethan Wang; Editing by Bernadette Baum)
About the Author
Reuterscontributor
Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV. Learn more about Thomson Reuters products:
Latest news and analysis
Advertisement